The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...

The Delhi High Court on February 3 passed an interim injunction restraining a pharmaceutical company from using the trademark ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

Chicago Partners Investment Group LLC bought a new stake in shares of Novartis AG (NYSE:NVS – Free Report) during the 4th ...

Super Bowl advertisers paid up to $8 million to secure a spot in television's most watched broadcast. Here's a lineup by ...

This launch builds on the successful collaboration between Dawn Health and Novartis, following the development of Ekiva MS and Ekiva PNH, and underscores the potential of digital health to transform ...

CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if ...

Though the big game has long been hallowed ground for some of the most entertaining and memorable commercials, they often don ...

Novartis AG (NVS) stock saw a modest uptick, ending the day at $105.48 which represents a slight increase of $0.76 or 0.73% from the prior close of $104.72. The stock opened at $104.47 and touched a ...

Fox sold out of its inventory of in-game spots by early November, with a 30-second commercial reportedly going for $7 million ...

Hailee Steinfeld and Issa Rae are leaving their mark on Super Bowl LIX by starring in their first Super Bowl commercials.

In February 2024, the government slashed GST (Goods and Services Tax) from three major cancer drugs: Trastuzumab Deruxtecan, ...